Major indices finish lower amid GE earnings disappointment >>> READ MORE

Pharmaceutical Stocks

Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like diabetes and even Ebola affecting more and more of the population, pharmaceutical companies are racing to find cures – further  advancing medicine and driving their stock prices up. Corporations like Pfizer (NYSE:PFE) and Gilead Sciences (NASDAQ:GILD) are leading the charge against disease but smaller companies such as Myland (NASDAQ:MYL) are interesting investments as well.

Recent Articles

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must More 

Could Quest Diagnostics Inc (DGX) Be The Last Remaining Undervalued Stock?

A huge disruptive even in January, 2018 will open the door for Quest Diagnostics to take the lead in its sector. Consider DGX stock now More 

4 Drug Stocks to Buy (CELG, EXEL, LGND, RDHL)

Here's a look at 4 drug stocks to buy preferred by analysts who have a deep knowledge and understanding of the industry and its companies. More 

5 Trump-Proof Pharma Dividend Stocks to Buy

Pharma is under the proverbial gun as Trump takes office, but these pharma dividend payers are stocks to buy for the long term More 

Avoid These 7 Big-Name Biotechs and Pharmaceuticals

Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More 

Why My Favorite Pick In Pharma Today is Eli Lilly and Co (LLY)

Big pharma has some great long-term drivers, and a wealth of these help power my favorite pharma pick, Eli Lilly. Look to LLY for value More 

3 Troubled Pharma Stocks That Could Rally Soon

Pharma stocks have been hit hard by scandals, public outcries and industry-related setbacks, but there's still hope for a recovery. More 

Valeant Pharmaceuticals Intl Inc’s Hard Times Mean Avoid VRX Stock

Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock More 

Bear of the Day: AbbVie Inc Slide Shows No Quick End (ABBV)

AbbVie Inc is under pressure as the government reviews a patent and competitor Coherus waits in the wings More 

Is Pfizer Inc. Finally Safe To Buy Again? (PFE)

A first-quarter earnings and revenue beat has investors excited once again with formerly beat-down Pfizer Inc. Is now the time to buy PFE? More